Affymax Inc (AFFY) financial statements (2020 and earlier)

Company profile

Business Address 19200 STEVENS CREEK BOULEVARD
CUPERTINO, CA 94014
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2014
TTM
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 678
Cash and cash equivalents 668
Short-term investments  10
Receivables  18
Advances on inventory purchases  18
Prepaid expense and other current assets16
Other undisclosed current assets  (17)
Total current assets: 6103
Noncurrent Assets
Property, plant and equipment  3
Long-term investments and receivables  2
Long-term investments  2
Restricted cash and investments  1
Prepaid expense and other noncurrent assets12
Other undisclosed noncurrent assets  7
Total noncurrent assets: 116
TOTAL ASSETS: 7118
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 172
Accounts payable 07
Accrued liabilities 153
Employee-related liabilities  13
Debt  9
Other undisclosed current liabilities 818
Total current liabilities: 999
Noncurrent Liabilities
Liabilities, other than long-term debt  11
Liability for uncertainty in income taxes  10
Restructuring reserve  (0)
Other liabilities  1
Other undisclosed noncurrent liabilities  0
Total noncurrent liabilities:  11
Total liabilities: 9110
Stockholders' equity
Stockholders' equity attributable to parent (1)8
Common stock 00
Additional paid in capital 557552
Accumulated other comprehensive loss  (0)
Accumulated deficit (558)(544)
Total stockholders' equity: (1)8
TOTAL LIABILITIES AND EQUITY: 7118

Income statement (P&L) ($ in millions)

6/30/2014
TTM
12/31/2013
12/31/2012
Gross profit: 194
Operating expenses (16)(186)
Operating loss: (15)(92)
Nonoperating income 00
Investment income, nonoperating 00
Other nonoperating income (expense) 0(0)
Interest and debt expense (2)(1)
Loss from continuing operations before income taxes: (17)(93)
Income tax benefit 20
Net loss available to common stockholders, diluted: (14)(93)

Comprehensive Income ($ in millions)

6/30/2014
TTM
12/31/2013
12/31/2012
Net loss: (14)(93)
Other comprehensive income (loss) 0(0)
Comprehensive loss, net of tax, attributable to parent: (14)(93)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: